PHI with Akinesia
How does this condition affect your private health insurance?
Akinesia, or akinesis, is a profound and debilitating symptom characterized by an inability to initiate voluntary movement. It is a hallmark feature of Parkinson's disease and other parkinsonian syndromes, often manifesting as 'freezing' episodes where individuals suddenly become unable to move, especially when starting a new action or navigating narrow spaces. This motor block is distinct from mere slowness (bradykinesia) and can lead to significant functional impairment, increasing the risk of falls and reducing independence. It's caused by neurodegeneration in the basal ganglia, disrupting motor control pathways. Management typically involves dopaminergic medications and physical therapy, aiming to improve motor initiation.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically insidious onset, developing over months or years as part of a progressive neurological condition. Initial episodes might be brief, lasting seconds to minutes.
Duration of Illness (Lifetime)
Chronic and progressive, typically lasting for the remainder of the patient's life once established, with fluctuating severity.
Cost of Treatment (Initial)
Initial diagnostic workup (neurological consultation, imaging, medication trials) can range from hundreds to several thousands of dollars.
Cost of Treatment (Lifetime)
Significant and ongoing, potentially tens of thousands to hundreds of thousands of dollars over a lifetime, including medications, therapies, assistive devices, and long-term care.
Mortality Rate
Akinesia itself is not directly fatal, but severe immobility can lead to complications like pneumonia, deep vein thrombosis, or falls, significantly increasing mortality risk, especially in advanced stages of underlying diseases.
Risk of Secondary Damages
Very high. Includes falls, fractures, aspiration pneumonia, social isolation, depression, anxiety, reduced quality of life, caregiver burden, and progressive loss of independence.
Probability of Full Recovery
Extremely low for the underlying conditions causing akinesia (e.g., Parkinson's disease). Symptomatic improvement with treatment is common but not a cure.
Underlying Disease Risk
Nearly 100%. Akinesia is almost always a symptom of an underlying neurological disorder, primarily Parkinson's disease, but also atypical parkinsonism (e.g., PSP, MSA), or drug-induced parkinsonism.